News
CSL and Arcturus Therapeutics Announce Nature Communications Has Published Pivotal Data Demonstrating Efficacy And Tolerability Of COVID-19 Vaccine
20 May 24
Biotech, News, General
Canaccord Genuity Maintains Buy on Arcturus Therapeutics, Lowers Price Target to $86
10 May 24
News, Price Target, Analyst Ratings
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
9 May 24
Biotech, Equities, News, Top Stories, Tech
Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate
8 May 24
Earnings, Earnings Beats, News
The Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Experts
11 Mar 24
Analyst Ratings
Canaccord Genuity Maintains Buy on Arcturus Therapeutics, Raises Price Target to $87
11 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $60 Price Target
8 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Arcturus Therapeutics Q4 Earnings
7 Mar 24
Earnings
Arcturus Therapeutics Q4 2023 GAAP EPS $(0.320) Beats $(0.760) Estimate, Sales $33.989M Miss $37.856M Estimate
7 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
Earnings Preview: Arcturus Therapeutics
6 Mar 24
Earnings
Press releases
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
20 May 24
Small Cap, Press Releases
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
20 May 24
Press Releases
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
15 May 24
Press Releases
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
8 May 24
Press Releases
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
25 Apr 24
Press Releases
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
7 Mar 24
Press Releases
Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
26 Feb 24
Press Releases
Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis
22 Feb 24
Press Releases